Evidence map›Paper›PMID 32339037›Full record

ArticleThe Journal of international medical research2020

Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma.

Xinjie Hao, Ruopei Xin, Wenjing Dong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Exosomes as potential diagnosis and treatment for liver cancer.World journal of gastrointestinal oncology · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xinjie HaoDepartment of Traditional Chinese Medicine, Qingdao No.6 People's Hospital, Qingdao, Shandong Province, China.
Ruopei XinDepartment of Traditional Chinese Medicine, Qingdao No.6 People's Hospital, Qingdao, Shandong Province, China.
Wenjing DongDepartment of Traditional Chinese Medicine, Qingdao No.6 People's Hospital, Qingdao, Shandong Province, China.ORCID https://orcid.org/0000-0003-1822-112X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorCarcinoma, HepatocellularExosomesFemaleGene ExpressionHumansLiver NeoplasmsMaleMicroRNAsMiddle AgedPrognosisBiomarkers, TumorMicroRNAsMIRN320 microRNA, humanbiomarkerdiagnosisexosomal miR-320ahepatocellular carcinomaprognosisSerum level

Identifiers

PMID32339037
PMCPMC7218457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.